Executive Director, Lifecycle Lead – New Technologies

Role Overview

• Lead integrated asset strategy across the full lifecycle, including research, clinical development, PV/PPQ, commercialization, and lifecycle management.
• Drive strategic planning for emerging therapeutic platform technologies.
• Evaluate portfolio opportunities and recommend development pathways, platform investments, and lifecycle expansion strategies.
• Partner with Research, Translational Sciences, and Clinical Development to enable seamless transition from discovery through development.
• Provide strategic oversight of manufacturing readiness, including process characterization, tech transfer, PV/PPQ, comparability, and supply chain readiness.
• Ensure alignment across Clinical Development, Manufacturing/MSAT & Supply, Quality, Regulatory, and Commercial teams for late-stage development and launch planning.
• Guide commercialization strategy, including launch readiness, market access, product differentiation, and lifecycle expansion.
• Partner with Project Management lead to develop and manage program timelines, action items, issues/risks and budget.
• Support governance decisions on manufacturing strategy, CDMO partnerships, network design, capacity planning, and commercial supply.
• Partner with Research, Translational Sciences, and Technical Development to advance next-generation therapeutic modalities and platform technologies.
• Ensure development strategies reflect platform-specific regulatory, manufacturing, clinical, and commercial considerations.
• Drive integrated multi-platform planning with focus on portfolio value and risk mitigation.
• Lead cross-functional planning for INDs, BLAs, label expansions, post-marketing commitments, and global lifecycle management.
• Work with third party technology and/or development partners to advance programs and operational plans

Requirements

• PhD, MBA or equivalent advanced degree preferred.
• 10+ years of experience in biotechnology or pharmaceutical drug development, including significant program leadership experience.
• Demonstrated experience managing programs through IND, pivotal studies, approval, and lifecycle expansion.
• Experience advancing platform technologies in a matrixed biotech environment.
• Strong end-to-end understanding of drug development (discovery through commercialization).
• Deep expertise in advanced therapy development, including autologous/allogeneic/in-vivo cell therapy, engineered viral vectors, lipid nanoparticles, polymer nanocarriers, gene editing technologies, and emerging platforms.
• Proven ability to drive cross functional teams, identify and escalate issues, influence senior leaders and align cross-functional governance.
• Success leading complex, cross-functional programs through major development and commercialization milestones.

Benefits

• Eligible for bonus
• Benefits
• Participation in Company’s stock plan